Does Payer Type Influence Pediatric Burn Outcomes? A National Study Using the Healthcare Cost and Utilization Project

Stephen Duquette1, Tahereh Soleimani, Brett Hartman

  • 1From the Division of Plastic Surgery, Department of Surgery, Indiana University School of Medicine, Indianapolis.

Insights

Children with Medicaid insurance experienced more complications and longer hospital stays from burns compared to those with private insurance or self-pay. Payer type significantly impacts pediatric burn outcomes.

Area of Science:

  • Pediatric medicine
  • Health services research
  • Burn injury outcomes

Background:

  • Pediatric burns represent a significant public health concern in the U.S.
  • Socioeconomic factors are known to affect disease outcomes.
  • Understanding disparities in burn care is crucial for improving patient management.

Purpose of the Study:

  • To investigate the association between payer type and outcomes in pediatric burn patients.
  • To analyze national data on pediatric burn injuries based on insurance status.
  • To identify potential socioeconomic disparities in burn care.

Main Methods:

  • Retrospective analysis of the Kids' Inpatient Database (KID) from 2000-2009.
  • Inclusion of patients aged 18 and under with burn-related diagnoses (Major Diagnostic code 22).
  • Statistical analysis including descriptive, bivariate, and multiple regression models to assess payer type's impact on complications and length of stay (LOS).

Main Results:

  • Medicaid was the primary payer for the majority of pediatric burn patients (52.3%).
  • Medicaid patients were younger, from lower-income zip codes, and had a higher proportion of African-American individuals.
  • Medicaid patients exhibited a higher overall complication rate and longer mean length of stay (LOS) compared to privately insured or self-pay patients.

Conclusions:

  • Payer type, specifically Medicaid coverage, is significantly associated with increased complications and longer LOS in pediatric burn patients.
  • These findings highlight socioeconomic disparities in pediatric burn care.
  • Further research and targeted interventions are needed to address these outcome differences and improve care for vulnerable pediatric burn populations.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
5.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.7K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762